Establishing a protocol to quantify leaflet fibroblast responses to physiologic flow through a viable heart valve

ASAIO Journal

Volumn 43, Issue 5, 1997, Pages

  Weston, Matthew W ^a   Goldstein, Steven ^b   Epting II, Robert E ^b   He, Shengqui ^a   Mauldin, Johnathan M ^a   Yoganathan, Ajit P ^a  

^a Georgia Institute of Technology   (United States)

^b CRYOLIFE INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTICS; BIOASSAY; HEMODYNAMICS; PHYSIOLOGY; PROTEINS; TISSUE;

CELLULAR VIABILITY; LEAFLET FIBROBLAST;

HEART VALVE PROSTHESES;

COLLAGEN TYPE 1; COLLAGEN TYPE 3;

ANIMAL TISSUE; AORTA VALVE PROSTHESIS; BIOPROSTHESIS; CELL VIABILITY; COLLAGEN SYNTHESIS; CONFERENCE PAPER; FIBROBLAST; HEART VALVE PROSTHESIS; HEART VALVE SURGERY; HEMODYNAMIC PARAMETERS; NONHUMAN; PROTEIN SYNTHESIS;

EID: 0031238471     PISSN: 10582916     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002480-199709000-00003     Document Type: Conference Paper

References (17)

1. Bloomfield P, Wheatley DJ, Prescott RJ, Miller HC: Twelve-year comparison of a Bjork-Shiley mechanical heart valve with porcine bioprostheses. N Engl J Med 324, 573-579, 1991.
2. Ferrans VJ, Spray TL, Billingham ME, Roberts WC: Structural changes in glutaraldehyde-treated porcine heterografts used as substitute cardiac valves: transmission and scanning electron microscopic observations in 12 patients. Am J Cardiol 41, 1159-1184, 1978.
3. Riddle JM, Jennings JJ, Stein PD, Magilligan DJ: A morphologic overview of the porcine bioprosthetic valve: before and after its degeneration. Scanning Electron Microscopy 1, 207-214, 1984.
4. Hilbert SJ, Ferrans VJ, Jones M: Tissue-derived biomaterials and their use in cardiovascular prosthetic devices. Med Prog Technol 14, 115-163, 1988.
5. O'Brien MF, Stafford G, Gardner M, et al: The viable cryopreserved allograft aortic valve. J Cardiac Surg 2(Suppl), 153-167, 1987.
6. McGiffin DC, O'Brien MF, Stafford EG, Gardner MA, Pohlner PG: Long-term results of the viable cryopreserved allograft aortic valve: continuing evidence for superior valve durability. J Cardiac Surg 3(Suppl), 289-296, 1988.
7. Dewey CF, Bussolari SR, Gimbrone MA, Davies PF: The dynamic response of vascular endothelial cells to fluid shear stress. J Biomech Eng 103, 177-185, 1981.
8. Wong AJ, Pollard TD, Herman IM: Actin filament stress fibers in vascular endothelial cells in vivo. Science 219, 867-869, 1983.
9. Reinhart WH: Shear-dependence of endothelial functions. Experentia 50, 87-93, 1994.
10. Resnick N, Collins T, Atkinson W, Bonthron DT, Dewey CF, Gimbrone MA: Platelet-derived growth factor B chain promoter contains a cis-acting fluid shear-stress-responsive element. Proc Natl Acad Sci USA 90, 4591-4595, 1993.
11. McIntire LV: 1992 ALZA distinguished lecture: bioengineering and vascular biology. Ann Biomed Eng 22, 2-13, 1994.
12. Reich KM, Gay CV, Frangos JA: Fluid shear stress as a mediator of osteoblast cyclic adenosine monophosphate production. J Cell Physiol 143, 100-104, 1990.
13. Rivas-Gotz CE, Centrella M, Sumpio BE: Stretch stimulates human keratinocyte but not dermal fibroblast proliferation. Surg Forum 46, 740-742, 1995.
14. Gray ML, Pizanelli AM, Lee RC, Grodzinsky AJ, Swann DA: Kinetics of the chondrocyte biosynthetic response to compressive load and release. Biochim Biophys Acts 991, 415-425, 1989.
15. Nimni ME: Collagen, structure and function. In Dulbecco R (ed), Encyclopedia of Human Biology, Volume 2, San Diego, Academic Press, 1991, pp. 559-574.
16. Hayashi T, Nagai Y: Separation of the a chains of type I and III collagens by SDS-polyacrylamide gel electrophoresis. J Biochem 86, 453-459, 1979.
17. McDonald JA, Broekelmann TJ, Matheke ML, Crouch E, Koo M, Kuhn C: A monoclonal antibody to the carboxyterminal domain of procollagen type I visualizes collagen-synthesizing fibroblasts: detection of an altered fibroblast phenotype in lungs of patients with pulmonary fibrosis. J Clin Invest 78, 1237-1244, 1986.